CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts. In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%. These positive trends can primarily be attributed to: An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)

An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Philippines healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Executive Summary

4Overview of Pharmaceutical and Medical Device Market ...

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Executive Summary

4Overview of Pharmaceutical and Medical Device Market

4.1Pharmaceutical Market

4.1.1Market Overview

4.1.2Pharmaceutical Exports and Imports

4.1.3Supply Channels

4.1.4Market Segments

4.1.5Overview of Major Disease Areas

4.1.6Major Players

4.2Medical Device Market

4.2.1Market Overview

4.3Market Drivers and Barriers

4.3.1Drivers

4.3.2Barriers

5Market Access

5.1Reimbursement and Payer Landscape

5.1.1Overview of Healthcare system

5.1.2Reimbursement Process

5.1.3Overview of Insurance Providers

5.1.4Patient Share in Healthcare Spending

5.1.5Price Trends in the Healthcare Sector

5.1.6Pricing Policies

5.2Regulatory Landscape

5.2.1Overview of Regulatory Agencies

5.2.2Market Authorization Procedure for Pharmaceutical Products

5.2.3New Medical Device Approval Process

5.2.4Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5Exports and Imports

5.2.6Intellectual Property Rights

5.2.7Clinical Trial Regulations

5.2.8Pharmaceutical Advertising Regulations

5.2.9Pharmacy Regulations

5.2.10Labeling and Packaging Regulations

6Country Analysis

6.1Political Environment

6.1.1Political Structure

6.1.2Analysis of Current Political Environment

6.1.3Healthcare Policy Initiatives

6.2Economic Landscape

6.3Economic Indicators

6.3.1Gross Domestic Product

6.3.2Gross National Income

6.3.3Inflation

6.3.4Currency Exchange Rate

6.3.5Foreign Direct Investment

6.3.6Foreign Exchange Reserves

6.3.7Trade Balance

6.3.8Fiscal Deficit

6.3.9General Government Gross Debt

6.3.10External Debt

6.3.11Major Industries

6.4Demographics

6.4.1Population

6.4.2Education and Literacy

6.4.3Employment

6.4.4Disease Burden

6.5Healthcare Infrastructure

6.5.1Healthcare Facilities

6.5.2Healthcare Parameters

6.5.3Environmental Health

6.5.4Healthcare Personnel

6.6Healthcare Expenditure

6.6.1Overview

6.6.2Major Components of Healthcare Spending

6.6.3Share of Public and Private Sector

6.6.4Spending in Pharmaceutical R&D

6.7Trade Associations

6.7.1Pharmaceutical and Healthcare Association of the Philippines

6.7.2The Philippine Pharmaceutical Manufacturers Association

6.7.3The Philippine Pharmacist Association

6.7.4The Philippine Medical Association

6.8Trade Fairs

7Opportunities and Challenges

7.1Opportunities

7.2Challenges

8Appendix

8.1Abbreviations

8.2Bibliography

8.3Research Methodology

8.3.1Coverage

8.3.2Secondary Research

8.3.3Forecasts

8.3.4Expert Panel

8.4Contact Us

8.5Disclaimer

List of Tables

Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016–2020

Table 3: Pharmaceutical Market, Philippines, Exports ...

Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016–2020

Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008–2014

Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008

Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016

Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015

Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016

Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014–2018

Table 11: Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck, 2016

Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016

Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016

Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008–2015

Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008–2014

Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008–2015

Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016–2020

Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008–2015

Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016–2020

Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008–2014

Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008–2013

Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008–2013

Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008–2015

Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008–2014

Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008–2014

Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008–2015

Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008–2015

Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008–2014

Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008–2015

Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008–2015

Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012–2013

Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013–2014

Table 34: Demographics, Philippines, Population (million), 2008–2015

Table 35: Demographics, Philippines, Population (million), 2016–2020

Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008–2015

Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016–2020

Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008–2015

Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020

Table 40: Demographics, Philippines, Births (per 1,000 Population), 2008–2014

Table 41: Demographics, Philippines, Mortality (per 1,000 Population), 2008–2014

Table 42: Demographics, Philippines, Major Causes of Mortality (‘000), 2013

Table 43: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 2008–2015

Table 44: Demographics, Philippines, Immunization Rate (%), 2008–2014

Table 45: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013

Table 46: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013

Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 2008–2014

Table 48: Demographics, Philippines, Gender Ratio (M:F), 2008–2014

Table 49: Demographics, Philippines, Life Expectancy at Birth (Years), 2008–2015

Table 50: Demographics, Philippines, Life Expectancy at Birth (Years), 2016–2020

Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008–2014

Table 52: Demographics, Philippines, Unemployment Rate (%), 2008–2015

Table 53: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013

Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009

Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008–2014

Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008–2014

Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009

Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 2007–2009

Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 2008–2014

Table 60: Environmental Health, Philippines, CO2 Emissions (Million Tons), 2008–2014

Table 61: Environmental Health, Philippines, PM2.5(µg/m³), 2008–2014

Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008–2014

Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008–2014

Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008–2014

Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013

Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008–2014

Table 67: Major Healthcare Trade Fairs, Philippines, 2016

List of Figures

Figure 1: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2008–2020

Figure 2: Country Profile, Philippines, 2016

Figure 3: Pharmaceutical Market, Philippines, Revenue ($bn), 2008–2015 ...

Figure 1: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2008–2020

Figure 2: Country Profile, Philippines, 2016

Figure 3: Pharmaceutical Market, Philippines, Revenue ($bn), 2008–2015

Figure 4: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016–2020

Figure 5: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008–2014

Figure 6: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008

Figure 7: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008

Figure 8: Healthcare Market, Philippines, Drivers and Barriers, 2016

Figure 9: Healthcare System, Philippines, 2016

Figure 10: Drug Selection Procedure for Philippine National Drug Formulary, Philippines, 2016

Figure 11: Reimbursement Process, Philippines, 2016

Figure 12: PhilHealth Milestones, Philippines, 2016

Figure 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016

Figure 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016

Figure 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008–2015

Figure 16: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008–2014

Figure 17: Food and Drug Administration Structure, Philippines, 2014

Figure 18: Approval Process of New Drugs and Medical Devices, Philippines, 2014

Figure 19: Approval Process of Generic Drugs, Philippines, 2016

Figure 20: Bureau of Health Devices and Technology Structure, Philippines, 2016

Figure 21: Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, Philippines, 2016

Figure 22: Patent Approval Process, Philippines, 2016

Figure 23: Trademark Approval Process, Philippines, 2016

Figure 24: Clinical Trial Approval Process, Philippines, 2014

Figure 25: Procedure for Opening a Retail Pharmacy, Philippines, 2014

Figure 26: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999–2014

Figure 27: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008–2015

Figure 28: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016–2020

Figure 29: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008–2015

Figure 30: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016–2020

Figure 31: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008–2014

Figure 32: Economic Indicators, Philippines, Average Consumer Price Index, 2008–2013

Figure 33: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008–2013

Figure 34: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008–2015

Figure 35: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008–2014

Figure 36: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008–2014

Figure 37: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008–2015

Figure 38: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008–2015

Figure 39: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008–2014

Figure 40: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008–2015

Figure 41: Economic Indicators, Philippines, External Debt ($bn), 2008–2015

Figure 42: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013–2014

Figure 43: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013–2014

Figure 44: Demographics, Philippines, Population (million), 2008–2015

Figure 45: Demographics, Philippines, Population (million), 2016–2020

Figure 46: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008–2015

Figure 47: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016–2020

Figure 48: Demographics, Philippines, Population Distribution by Age Group (%), 2008–2015

Figure 49: Demographics, Philippines, Population Distribution by Age Group (%), 2016–2020

Figure 50: Demographics, Philippines, Births (per 1,000 Population), 2008–2014

Figure 51: Demographics, Philippines, Mortality (per 1,000 Population), 2008–2014

Figure 52: Demographics, Philippines, Major Causes of Mortality (‘000), 2013

Figure 53: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 2008–2015

Figure 54: Demographics, Philippines, Immunization Rate (%), 2008–2014

Figure 55: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013

Figure 56: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013

Figure 57: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 2008–2014

Figure 58: Demographics, Philippines, Gender Ratio (M:F), 2008–2014

Figure 59: Demographics, Philippines, Life Expectancy at Birth (Years), 2008–2015

Figure 60: Demographics, Philippines, Life Expectancy at Birth (Years), 2016–2020

Figure 61: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008–2014

Figure 62: Demographics, Philippines, Unemployment Rate (%), 2008–2015

Figure 63: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013

Figure 64: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009

Figure 65: Healthcare Infrastructure, Philippines, Hospitals, 2008–2014

Figure 66: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008–2014

Figure 67: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009

Figure 68: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 2007–2009

Figure 69: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 2008–2014

Figure 70: Environmental Health, Philippines, CO2 Emissions (Million Tons), 2008–2014

Figure 71: Environmental Health, Philippines, PM2.5 (µg/m³), 2008–2014

Figure 72: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008–2014

Figure 73: Healthcare Personnel, Philippines, Registered Nurses, 2008–2014

Figure 74: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008–2014

Figure 75: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013

Figure 76: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008–2014

Figure 77: Healthcare Market, Philippines, Opportunities and Challenges, 2016

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

GlobalData's customer service is great because they find creative ways to support our requests and always go the extra mile!

  Jabil Circuit